Mylan N.V. (MYL) PT Set at $34.00 by Cantor Fitzgerald
Mylan N.V. (NASDAQ:MYL) has been given a $34.00 price target by analysts at Cantor Fitzgerald in a research report issued on Wednesday. The firm presently has a “hold” rating on the stock. Cantor Fitzgerald’s price target indicates a potential upside of 6.95% from the stock’s previous close.
Other research analysts have also issued reports about the company. Royal Bank Of Canada set a $41.00 price target on Mylan N.V. and gave the stock a “hold” rating in a research report on Saturday, May 13th. Wells Fargo & Company set a $30.00 price target on Mylan N.V. and gave the stock a “hold” rating in a research report on Wednesday. Morgan Stanley reduced their price target on Mylan N.V. from $52.00 to $36.00 and set an “equal weight” rating on the stock in a research report on Monday. Cowen and Company reaffirmed a “market perform” rating and set a $43.00 price objective (down previously from $55.00) on shares of Mylan N.V. in a research note on Sunday, May 21st. Finally, Zacks Investment Research raised Mylan N.V. from a “sell” rating to a “hold” rating in a research note on Tuesday, August 1st. Two investment analysts have rated the stock with a sell rating, eleven have given a hold rating, twelve have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average target price of $49.40.
Shares of Mylan N.V. (NASDAQ:MYL) traded down 0.85% during midday trading on Wednesday, hitting $31.52. The stock had a trading volume of 24,216,122 shares. The stock has a 50 day moving average price of $38.19 and a 200-day moving average price of $39.19. The stock has a market capitalization of $16.89 billion, a price-to-earnings ratio of 31.49 and a beta of 1.27. Mylan N.V. has a 52 week low of $29.58 and a 52 week high of $50.40. Mylan N.V. also was the target of unusually large options trading on Monday. Traders purchased 9,410 call options on the stock. This represents an increase of 250% compared to the typical daily volume of 2,688 call options.
Mylan N.V. (NASDAQ:MYL) last posted its quarterly earnings results on Wednesday, August 9th. The company reported $1.10 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $1.18 by $0.08. Mylan N.V. had a return on equity of 23.69% and a net margin of 4.59%. The company had revenue of $2.96 billion during the quarter, compared to the consensus estimate of $3 billion. During the same quarter in the prior year, the business earned $1.16 earnings per share. The firm’s revenue for the quarter was up 15.7% on a year-over-year basis. Equities research analysts anticipate that Mylan N.V. will post $5.12 earnings per share for the current year.
In related news, insider Anthony Mauro sold 10,000 shares of Mylan N.V. stock in a transaction dated Friday, June 9th. The stock was sold at an average price of $40.00, for a total value of $400,000.00. Following the sale, the insider now owns 140,653 shares of the company’s stock, valued at $5,626,120. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, President Rajiv Malik sold 25,000 shares of Mylan N.V. stock in a transaction dated Friday, June 9th. The shares were sold at an average price of $40.00, for a total value of $1,000,000.00. Following the completion of the sale, the president now directly owns 799,855 shares in the company, valued at approximately $31,994,200. The disclosure for this sale can be found here. 0.69% of the stock is currently owned by insiders.
Several hedge funds have recently added to or reduced their stakes in MYL. Wellington Management Group LLP increased its stake in Mylan N.V. by 2.6% in the first quarter. Wellington Management Group LLP now owns 46,373,108 shares of the company’s stock worth $1,808,088,000 after buying an additional 1,165,852 shares in the last quarter. BlackRock Inc. increased its stake in Mylan N.V. by 3,447.5% in the first quarter. BlackRock Inc. now owns 38,822,643 shares of the company’s stock worth $1,513,696,000 after buying an additional 37,728,274 shares in the last quarter. Vanguard Group Inc. increased its stake in Mylan N.V. by 3.9% in the first quarter. Vanguard Group Inc. now owns 29,348,816 shares of the company’s stock worth $1,144,310,000 after buying an additional 1,090,791 shares in the last quarter. State Street Corp increased its stake in Mylan N.V. by 1.2% in the first quarter. State Street Corp now owns 20,176,564 shares of the company’s stock worth $786,700,000 after buying an additional 234,521 shares in the last quarter. Finally, Pzena Investment Management LLC increased its stake in Mylan N.V. by 69.9% in the second quarter. Pzena Investment Management LLC now owns 12,339,687 shares of the company’s stock worth $479,027,000 after buying an additional 5,077,371 shares in the last quarter. 70.19% of the stock is currently owned by institutional investors and hedge funds.
About Mylan N.V.
Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty.
Receive News & Ratings for Mylan N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan N.V. and related companies with MarketBeat.com's FREE daily email newsletter.